Second allogeneic bone marrow transplantation (BMT) for AML relapsing after an initial BMT has a poor prognosis, with a probability of a 2-y disease-free survival below 30 per cent, caused both by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback